These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2883064)

  • 1. Effects of hexamethonium and atropine on the basal levels of immunoreactive vasoactive intestinal polypeptide in dogs.
    Misawa T; Chijiiwa Y; Ibayashi H
    Gastroenterol Jpn; 1986 Dec; 21(6):579-83. PubMed ID: 2883064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of local mechanism involvement in vasoactive intestinal polypeptide release from canine small intestine.
    Chijiiwa Y; Misawa T; Ibayashi H
    Gastroenterology; 1986 Jun; 90(6):1877-81. PubMed ID: 2870952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corelease of PHI and VIP by vagal stimulation in the dog.
    Yasui A; Naruse S; Yanaihara C; Ozaki T; Hoshino M; Mochizuki T; Daniel EE; Yanaihara N
    Am J Physiol; 1987 Jul; 253(1 Pt 1):G13-9. PubMed ID: 2886054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of VIP and substance P from isolated perfused canine ileum.
    Manaka H; Manaka Y; Kostolanska F; Fox JE; Daniel EE
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G182-90. PubMed ID: 2475029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory mechanisms in the luminal and portal release of vasoactive intestinal polypeptide during vagal nerve stimulation in the cat.
    Blank MA; Kimura K; Jaffe BM
    Regul Pept; 1988 Oct; 23(1):15-26. PubMed ID: 2907169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural release of vasoactive intestinal peptide from the gut.
    Bitar KN; Said SI; Weir GC; Saffouri B; Makhlouf GM
    Gastroenterology; 1980 Dec; 79(6):1288-94. PubMed ID: 7439634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum.
    Lundberg JM; Anggård A; Fahrenkrug J
    Acta Physiol Scand; 1981; 113(3):329-36. PubMed ID: 7345899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum.
    Fujimiya M; Yamamoto H; Kuwahara A
    Am J Physiol; 1998 Oct; 275(4):G731-9. PubMed ID: 9756504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs.
    Havel PJ; Dunning BE; Verchere CB; Baskin DG; O'Dorisio T; Taborsky GJ
    Regul Pept; 1997 Aug; 71(3):163-70. PubMed ID: 9350974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of vasoactive intestinal polypeptide into the cerebrospinal fluid of the fourth ventricle of the rat: involvement of cholinergic mechanism.
    Kaji H; Chihara K; Minamitani N; Kodama H; Yanaihara N; Fujita T
    Brain Res; 1983 Jun; 269(2):303-10. PubMed ID: 6136311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of circular muscle motility of the isolated perfused canine ileum: relationship to VIP output.
    Fox-Threlkeld JE; Manaka H; Manaka Y; Cipris S; Daniel EE
    Peptides; 1991; 12(5):1039-45. PubMed ID: 1686931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagal release of IR-VIP and IR-gastrin from the isolated perfused rat stomach.
    Pederson R; O'Dorisio T; Howe B; McIntosh C; Mueller M; Brown J; Cataland S
    Mol Cell Endocrinol; 1981 Aug; 23(2):225-31. PubMed ID: 7274550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide released by acetylcholine in the dog ileum.
    Kimura H; Ito S; Ohta T; Asano T; Nakazato Y
    J Auton Nerv Syst; 1994 Jul; 48(2):167-74. PubMed ID: 8089398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in the control of exocrine pancreatic secretion in the interdigestive state in the rabbit.
    Montero A; Bragado J; Alonso RM; García LJ; Calvo JJ; López MA
    Rev Esp Fisiol; 1993 Jun; 49(2):93-9. PubMed ID: 8104355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric vasodilatation and vasoactive intestinal peptide output in response to vagal stimulation in the dog.
    Ito S; Ohga A; Ohta T
    J Physiol; 1988 Oct; 404():669-82. PubMed ID: 2908127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic control mechanisms for immunoreactive motilin release and motility in the canine duodenum.
    Fox JE; Daniel EE; Jury J; Track NS; Chiu S
    Can J Physiol Pharmacol; 1983 Sep; 61(9):1042-9. PubMed ID: 6139157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic inactivation of vasoactive intestinal peptide in man and dog.
    Ebeid AM; Escourrou J; Soeters PB; Murray P; Fischer JE
    Ann Surg; 1978 Jul; 188(1):28-33. PubMed ID: 666373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP and noncholinergic vasodilatation in rabbit submandibular gland.
    Fazekas A; Gazelius B; Edwall B; Theodorsson-Norheim E; Blomquist L; Lundberg JM
    Peptides; 1987; 8(1):13-20. PubMed ID: 2437546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP as a mediator of hexamethonium-sensitive, atropine-resistant vasodilation in the cat tongue.
    Lundberg JM; Anggård A; Fahrenkrug J
    Acta Physiol Scand; 1982 Dec; 116(4):387-92. PubMed ID: 6189365
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of VIP-like immunoreactivity in response to dopamine agonists, insulin hypoglycemia and feeding in conscious dogs.
    Uvnäs-Moberg K; Goiny M; Blomquist LE; Elwin CE
    Peptides; 1984; 5(2):399-402. PubMed ID: 6147818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.